通化金马：公司研制的化学1类新药琥珀八氢氨吖啶片目前已完成综合审评工作，进入最后审评环节

Group 1 - The company Tonghua Golden Horse (000766.SZ) has completed the comprehensive review of its chemical Class 1 new drug, Amber Dihydroaminoacridine Tablets, and has provided the required professional research materials, entering the final review stage [2] - The progress of all related work for the new drug is reported to be normal [2] - The company will disclose any significant information regarding the new drug through designated information disclosure media, urging investors to pay attention to company announcements [2]